CA2089258A1 - Lymphokine 154 - Google Patents

Lymphokine 154

Info

Publication number
CA2089258A1
CA2089258A1 CA002089258A CA2089258A CA2089258A1 CA 2089258 A1 CA2089258 A1 CA 2089258A1 CA 002089258 A CA002089258 A CA 002089258A CA 2089258 A CA2089258 A CA 2089258A CA 2089258 A1 CA2089258 A1 CA 2089258A1
Authority
CA
Canada
Prior art keywords
protein
present
sequence given
lymphokine
dna segment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002089258A
Other languages
English (en)
Inventor
Kathleen Kelly
Ulrich Siebenlist
Kevin S. Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Commerce
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2089258A1 publication Critical patent/CA2089258A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002089258A 1990-08-13 1991-08-13 Lymphokine 154 Abandoned CA2089258A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56610890A 1990-08-13 1990-08-13
US566,108 1990-08-13
PCT/US1991/005749 WO1992003466A1 (fr) 1990-08-13 1991-08-13 Lymphokine 154

Publications (1)

Publication Number Publication Date
CA2089258A1 true CA2089258A1 (fr) 1992-02-14

Family

ID=24261524

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002089258A Abandoned CA2089258A1 (fr) 1990-08-13 1991-08-13 Lymphokine 154

Country Status (5)

Country Link
EP (1) EP0544743A4 (fr)
JP (1) JPH05508778A (fr)
AU (1) AU8446891A (fr)
CA (1) CA2089258A1 (fr)
WO (1) WO1992003466A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0948531A1 (fr) * 1996-12-11 1999-10-13 Chiron Corporation Proteines humaines secretees

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92685A0 (en) * 1988-12-16 1990-09-17 Us Commerce Dna encoding lymphokine/cytokine like proteins,cells transformed thereby and production of said proteins and antibodies against them

Also Published As

Publication number Publication date
JPH05508778A (ja) 1993-12-09
WO1992003466A1 (fr) 1992-03-05
EP0544743A1 (fr) 1993-06-09
AU8446891A (en) 1992-03-17
EP0544743A4 (en) 1994-05-18

Similar Documents

Publication Publication Date Title
Gimbrone Jr et al. Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions
US4490289A (en) Homogeneous human interleukin 2
Tanabe et al. Identification of a new mouse beta-chemokine, thymus-derived chemotactic agent 4, with activity on T lymphocytes and mesangial cells.
Singh et al. Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo.
ES2343518T3 (es) Polipeptidos interferon alfa modificados resistentes a proteasas.
KR0148009B1 (ko) 인터루킨-1 억제제
KR100210308B1 (ko) 신규 폴리펩티드 및 이를 암호하는 디엔에이(dna)
JP2952750B2 (ja) モノクローナル抗体
WO2000034317A2 (fr) Modification de l'immunogenicite de proteines
JP2007267750A (ja) 可溶性ｉｌ−ｔｉｆ／ｉｌ−２２レセプターまたはｉｌ−ｔｉｆ／ｉｌ−２２に結合する結合タンパク質をコードする単離された核酸分子、およびその使用
KR970002917B1 (ko) 인터루킨-i 억제제
EP0491878B1 (fr) Compositions pour l'inhibition de la formation d'hormones proteiques et emplois de celles-ci
CA2006964A1 (fr) Produit de proteine purifie d'origine humaine attirant les monocytes utile dans le traitement des infections et des neoplasmes chez les humains et clonage de leur adn-c
KR19980079551A (ko) 폴리펩티드
JP2805008B2 (ja) 生物活性の人ｉｌ−１蛋白質
JP2004529633A (ja) 低減された免疫原性を有する修飾されたヒトインターフェロンベータ
KR100270348B1 (ko) 전사인자 에이피알에프
AggarwalS et al. Human tumor necrosis factor
EP0273373A2 (fr) Peptides et leur production
CA2089258A1 (fr) Lymphokine 154
US5434247A (en) Peptides for inducing monocyte cytotoxicity in diagnostics
Weller et al. Eosinophil granule cationic proteins: major basic protein is distinct from the smaller subunit of eosinophil peroxidase
Sarfati et al. T-cell-derived IgE-binding factors. II. Purification and characterization of IgE-binding factors produced by human T cell leukemia/lymphoma virus-1-transformed T lymphocytes.
EP0256042A1 (fr) Interleukine
WO1991012334A1 (fr) Inhibiteur de l'activite des cytokines et applications de celui-ci

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued